An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles

被引:116
作者
Xu, C
Rao, YS
Xu, B
Hoffmann, E
Jones, J
Sellers, EM
Tyndale, RF
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[3] Washington State Univ, Dept Chem, Pullman, WA 99163 USA
关键词
genetic polymorphism; CYP2A6; substrate recognition sites; nicotine; coumarin; smoking;
D O I
10.1006/bbrc.2001.6209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We developed genotyping assays for CYP2A6*7 (Ile471Thr) and CYP2A6*8 (Arg485Leu). We found higher allelic frequencies in Japanese and Chinese versus Caucasians and identified an allele in which both substitutions occur together (CYP2A6*10). We created a homology model for predicting the impact of allelic variants on enzymatic activity and subsequently tested this in vivo in a pilot kinetic study. Consistent with our homology model predictions, we found (i) that CYP2A6*7 produces an enzyme that has decreased (not inactive) activity for metabolizing nicotine and coumarin; (ii) that CYP2A6*8 is unlikely to affect catalytic activity in vivo; and (iii) that having both substitutions together on an allele (CYP2A6*10) dramatically reduces function and may be fully inactive for some substrates. In conclusion, this study identifies, at relatively high frequency in Asians, an allele with decreased activity (may be substrate selective), a fully functional allele, and an allele containing both substitutions in which function is dramatically reduced. (C) 2002 Elsevier Science.
引用
收藏
页码:318 / 324
页数:7
相关论文
共 25 条
[1]   A novel single nucleotide polymorphism altering stability and activity of CYP2A6 [J].
Ariyoshi, N ;
Sawamura, Y ;
Kamataki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (03) :810-814
[2]  
Chen W., UNPUB
[3]   RAPID AND SENSITIVE DETERMINATION OF COUMARIN AND 7-HYDROXYCOUMARIN AND ITS GLUCURONIDE CONJUGATE IN URINE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
EGAN, DA ;
OKENNEDY, R .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 582 (1-2) :137-143
[4]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
[5]  
GOODZ S, IN PRESS CYTOCHROM C
[6]  
GOTOH O, 1992, J BIOL CHEM, V267, P83
[7]  
Hoffman SMG, 1995, J MOL EVOL, V41, P894
[8]  
ISCAN M, 1994, EUR J CLIN PHARMACOL, V47, P315
[9]   CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity [J].
Kitagawa, K ;
Kunugita, N ;
Kitagawa, M ;
Kawamoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :17830-17835
[10]  
Messina ES, 1997, J PHARMACOL EXP THER, V282, P1608